237 related articles for article (PubMed ID: 19765801)
1. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
[TBL] [Abstract][Full Text] [Related]
2. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of YKL-40 protein in epithelial ovarian cancer tissues.
Yang GF; Cai PY; Li XM; Deng HX; He WP; Xie D
Ai Zheng; 2009 Feb; 28(2):142-5. PubMed ID: 19550125
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.
Kim SH; Das K; Noreen S; Coffman F; Hameed M
World J Surg Oncol; 2007 Feb; 5():17. PubMed ID: 17286869
[TBL] [Abstract][Full Text] [Related]
5. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer.
Yamac D; Ozturk B; Coskun U; Tekin E; Sancak B; Yildiz R; Atalay C
Adv Ther; 2008 Aug; 25(8):801-9. PubMed ID: 18670741
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
[TBL] [Abstract][Full Text] [Related]
7. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
[TBL] [Abstract][Full Text] [Related]
9. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.
Johansen JS; Christensen IJ; Riisbro R; Greenall M; Han C; Price PA; Smith K; Brünner N; Harris AL
Breast Cancer Res Treat; 2003 Jul; 80(1):15-21. PubMed ID: 12889595
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
[TBL] [Abstract][Full Text] [Related]
12. YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.
Roslind A; Knoop AS; Jensen MB; Johansen JS; Nielsen DL; Price PA; Balslev E
Breast Cancer Res Treat; 2008 Nov; 112(2):275-85. PubMed ID: 18157633
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection.
Cao Y; Liu H; Zhang H; Lin C; Li R; Zhang W; Shen Z; Xu J
Tumour Biol; 2016 Aug; 37(8):10883-91. PubMed ID: 26883254
[TBL] [Abstract][Full Text] [Related]
15. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
17. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
19. Early detection and prognosis of ovarian cancer using serum YKL-40.
Dupont J; Tanwar MK; Thaler HT; Fleisher M; Kauff N; Hensley ML; Sabbatini P; Anderson S; Aghajanian C; Holland EC; Spriggs DR
J Clin Oncol; 2004 Aug; 22(16):3330-9. PubMed ID: 15310777
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.
Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH
Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
